TNNI3 and familial dilated cardiomyopathy: Due to the atypical clinical manifestations of DCM, current clinical diagnosis of this disease is limited and is mainly based on the comprehensive evaluation of the patient’s medical history, symptoms, echocardiography, magnetic resonance imaging, and some emerging biomarkers, such as serum HbA1c and cTnI levels.